The Launch Decisions

Every Development Decision Is Also a Commercial Decision

Every development decision is also a commercial decision, whether or not anyone in the room is treating it that way.

Every development decision is also a commercial decision, whether or not anyone in the room is treating it that way.

It’s easy to miss that when you’re early in your clinical-stage journey. The choices that most determine a product’s commercial future are made by clinical, regulatory, and scientific experts, at a stage when “commercial” is something the company plans to build later. So the decisions get made on their scientific merits alone, and their commercial consequences go unnoticed until after they’re set.

Consider what actually gets decided in development. The endpoint you power the pivotal trial for is the claim you’ll eventually be able to make, or the one you’ll wish you could. The comparator you choose determines whether you’ll have the data a payer needs to justify coverage; the payer sets the bar from the market and their own criteria, and your comparator drives whether you can meet it. The subgroups you enroll, or don’t, decide which patients you’re legally allowed to speak to once the label is written, and how credibly. The dosing regimen shapes adherence, cost, and how a prescriber weighs you against whatever else is available. None of these decisions is labeled commercial when it’s made. In reality, all of them are.

The reason this happens isn’t carelessness. It’s sequencing. The choices with the largest commercial consequences are made when uncertainty is highest and there’s no commercial organization to weigh in. By the time one exists, the calls are already made, and the work shifts from shaping the outcome to executing whatever those earlier decisions made possible.

This is why I think of commercialization as something that begins in development, not after it. Not because an early-stage team needs a commercial department. It doesn’t. It’s because the questions it’s weighing are already commercial, and someone with commercial expertise should be weighing in while the answers can still change the trajectory.

The fix isn’t to resolve every one of these decisions early. It’s to surface them early: to name the commercial consequence out loud, while the choice is still open. A decision made on purpose can still be a hard one. A decision made by default is just a consequence you haven’t run into yet.

The best launches I’ve seen weren’t rescued at the end. Their success was made close to inevitable by the quality of the thinking brought to decisions no one else was calling commercial at the time.

The decisions you make today determine commercial success years from now.

© 2026 Kavros Advisors